
AAOS2019: TXA vs. EACA vs. control on pain and function in an ACL reconstruction

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
45 patients scheduled for anterior cruciate ligament reconstruction were randomized to receive tranexamic acid (TXA), epsilon aminocaproic acid (EACA) or no intervention. Outcomes of interest included pain on a visual analog scale, Lysholm score, knee range of motion, and degree of hemarthrosis. The results from this study found significantly favourable pain scores in the TXA group compared to the...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Join the Conversation
Please Login or Join to leave comments.